AMED250117C90000
- 2.31
- +0.11+5.00%
Amedisys Newsroom
UnitedHealth Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
UnitedHealth Group Terminates Deal for Sale of Certain Amedisys and UnitedHealth Assets to VitalCaring Group
Express News | Amedisys Inc - on Jan 3, UnitedHealth Group Terminates Vcg Purchase Agreement With Vcg Luna
Amedisys Currently Up 12 Consecutive Days, on Pace for Longest Winning Streak Since May 2017 -- Data Talk
Jefferies Maintains Amedisys(AMED.US) With Hold Rating, Maintains Target Price $101
Pulse Episodes Sees Rapid Growth, Now Supports Over 25% of US Home Health Average Daily Census
William Blair Maintains Amedisys(AMED.US) With Hold Rating
Reasons to Retain AMED Stock in Your Portfolio Now
Due to facing strict scrutiny, UnitedHealth and Amedisys plan to extend the deadline for their merger Trade.
Gelonghui, December 30 | According to a document cited by Reuters, UnitedHealth and Amedisys have agreed to extend the deadline for completing the $3.3 billion merger agreement until next year, as the Trade is facing strict scrutiny from the USA Department of Justice. Over a month ago, the USA Department of Justice and three states filed a lawsuit to block the Trade, citing concerns that it would reduce competition in the home health services market. The document stated that the two companies have reached a new waiver agreement, extending the merger deadline to 10 days after the final court ruling on the lawsuit or December 31, 2025, whichever comes first.
UnitedHealth, Amedisys Waive Right to Terminate Merger Pact
Sector Update: Health Care Stocks Lower in Late Afternoon Trading
US Equities Markets End Lower Friday as Big Tech Slumps
Equities Fall Intraday as Mega-Cap Stocks Weigh
Top Stock Movers Now: Lamb Weston, Amedisys, Supermicro, and More
Stocks Fall, Amedisys Deal Extension, Netflix-NFL Record: Market Minute
Nasdaq Leads Market Losses in Midday Trading
US Equity Indexes Lower in Midday Trading
Top Midday Stories: UnitedHealth, Amedisys Extend Deal-Close Deadline; OpenAI Mulling a For-Profit Structure
UnitedHealth, Amedisys Extend Merger Deadline Amid Regulatory Scrutiny
TD Cowen Maintains Amedisys(AMED.US) With Hold Rating, Maintains Target Price $101